6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.
AUTOR(ES)
Koszalka, G W
RESUMO
A series of 6-alkylaminopurine arabinosides were synthesized and found to inhibit varicella-zoster virus (VZV). The antiviral activities of these nucleosides were limited to VZV. None of the other viruses tested in the herpesvirus family were affected. The in vitro antiviral potencies of the 18 arabinosides correlated with their efficiencies as substrates of the VZV-encoded thymidine kinase in all but one case. The arabinosides of 6-methylaminopurine and 6-dimethylaminopurine were the most potent analogs, with 50% inhibitory concentrations against VZV of 3 and 1 microM, respectively. They were not cytotoxic to uninfected MRC-5 cells, human Detroit 98 cells, or mouse L cells (50% inhibitory concentration, greater than 100 microM). Neither 6-methylaminopurine arabinoside nor 6-dimethylaminopurine arabinoside was detectably phosphorylated by either adenosine kinase or 2'-deoxycytidine kinase. These two alkylaminopurine arabinosides were also resistant to deamination catalyzed by adenosine deaminase. The VZV-dependent phosphorylation of these nucleosides offers the possibility of a potent and highly selective therapy for VZV infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245186Documentos Relacionados
- 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.
- Selective anabolism of 6-methoxypurine arabinoside in varicella-zoster virus-infected cells.
- Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.
- Varicella-zoster virus.
- Neutralizing antibody responses to varicella-zoster virus.
